The cardiorespiratory responses to an l.v. infusion of dobutamine hydrochloride were assessed in eight anaesthetized, mechanically ventilated dogs As the rate of infusion of dobutamine was increased from 2 to 30ngkg~'min~1, there was a progressive decrease in arterial pressure, pulmonary wedge pressure and arterial pH. There was a sigmf icant decrease in arterial oxygen tension at the greater doses of dobutamine (15 and 30/xgkg* 1 min" 1 ) from initial control values. Carbon dioxide output, arterial carbon dioxide tension, venous admixture and oxygen consumption increased during the infusion of dobutamine. However, oxygen supply increased further so that the oxygen consumption: supply ratio decreased It is concluded that dobutamine may decrease arterial oxygen tension, but that the increased cardiac output and decreased arterial pH produced by dobutamine may increase oxygen supply to the tissues m spite of this.
Dobutamine hydrochloride (Dobutrex) is a new ft adrenergic agonist, developed by systematic modification of isoprenaline (Tuttle and Mills, 1975) . The most common clinical inotropic agents, isoprenaline and dopamine, have actions apart from those on the heart and have both been shown to cause arterial hypoxaemia (Fordham and Resnekov, 1968; Lemaireet al., 1976) . It was of interest, therefore, to look at the cardiorespiratory effects of the new, relatively cardiospecific synthetic catecholamine, dobutamine hydrochloride, given in a series of doses within the range used clinically (2-30 tig kg" 1 min" 1 ) to anaesthetized, mechanically ventilated dogs.
METHODS
Eight dogs of various breeds, weights 20-36 kg (mean± SEM = 22.7±2.54kg) were anaesthetized with thiopentone 20-30 mg kg" 1 and pentobarbitone 60-240 mg. The dogs were placed supine in a V-shaped trough, in tuba ted, and ventilated at 15 b.p.m. via a non-rebreathing valve (Sykes, 1969) from which expired gas could be collected. Tidal volume was adjusted to give an end-tidal carbon dioxide concentration close to 4.5%. The right femoral artery and vein were cannulated for measurement of cardiac output by dye dilution. The left femoral artery was cannulated for mean aortic pressure (PAD) measurement and the withdrawal of arterial blood samples. The left femoral vein was cannulated for the administration of dobutamine and saline. A cannula was passed through the right external jugular vein into the pulmonary artery for the measurement of mean pulmonary artery pressure (PPS) and the withdrawal of mixed venous blood samples. Mean pulmonary wedge pressure (Pw) was measured via a pulmonary artery catheter passed from the left external jugular vein. All pressures were measured using Consolidated Electrodynamics strain gauges and a heated stylus recorder. Anaesthesia was maintained with increments of thiopentone and pentobarbitone administered via a cannula placed in the left cephalic vein. Dog temperature, measured using a thermistor placed in the lower half of the oesophagus, was maintained at a mean temperature of 36.8 °C± 0.2 (± SEM) by means of a heater under the trough.
The experimental programme consisted of an initial control period during which saline was infused into the left femoral vein at 0.1 ml min "' by a calibrated infusion pump. The infusion was then changed to dobutamine infused at the same rate to give a dose of 2 ng kg" • min" •. The infusion rate was subsequently increased to give doses of 7.5, 15 and 30/xgkg" 1 min" 1 of dobutamine followed by a final control period in which saline was infused at the same rate as the final dose of dobutamine (l.Smlmin l ) . Each period of drug infusion lasted approximately 20min. The time between the cessation of the dobutamine infusion and the final control measurements was at least 45 min. The total volume of fluid infused was never greater than 150 ml, and the time taken to complete the programme never exceeded 3.5h.
When a steady state had been reached, determined by vascular pressures and end-tidal carbon dioxide, a full set of measurements was taken in each control period and during each rate of dobutamine infusion. This consisted of drawing arterial and mixed venous blood samples which were analysed in duplicate for POz, Pc&z, pH and haemoglobin concentration, duplicate measurements of cardiac output, measurement of PKQ, PFA, Pw, end-tidal carbon dioxide, mixed expired carbon dioxide and oxygen concentrations, expired gas temperature and volume and airway pressure (measured between the endotracheal tube and the collect valve).
Alveolar-arterial PO2 difference (PAO 2 -venous admixture (Ova/(Jt), oxygen uptake ( carbon dioxide production ( VtO 2 ) and physiological deadspace (VD/Vr***) were calculated from the measured variables using the computer program of Adams (1970) Although oxygen consumption increased significantly during infusion of dobutamine, oxygen supply increased further, so that the oxygen consumption: supply ratio decreased during the dobutamine infusion. However, this was greater than the initial control values during the final control period.
No significant changes in airway pressure, PPA, PVR, (PAo 2 -Pao 2 ) and Qt occurred.
The cardiovascular measurements are summarized in table I and respiratory measurements in table II. Changes in blood-gases, vascular pressures and cardiac output and oxygen consumption and supply are shown in figures 1,2, and 3. In this study, some measurements during the final control period were significantly different from those made during the initial control period. All measurements were, however, returning towards the initial control values. This suggests either a time effect, or that dobutamine, despite a plasma half-life of only 2 min in the dog (Fasola, Lemberger and Murphy, 1976; Murphy, Williams and Kau, 1976) has an action, or products of its action, which persist for longer than 45 min (the time between S$ and S<s). However, the recorded values were stable before the final control measurements were taken, which suggests a time effect caused by a change in condition of the preparation. The short half-life of dobutamine and the stability of measurements when a sample was taken at a particular infusion rate suggest that, despite a cumulative infusion, the effect seen at each dose rate represented those produced by that infusion rate. This view is partly supported by the findings of Anggard and colleagues (1978) who showed that, 30 min after discontinuing a dobutamine infusion, the plasma concentration of the drug had returned to the control value.
Although the plasma dobutamine concentration was not measured in the present study, Anggard and others showed a linear correlation between the infusion rate of dobutamine and plasma concentrations, with an infusion rate of Sugkg^min" 1 giving a mean plasma concentration of 65ngml~1 and an infusion rate of 15 ng kg"' min ~' giving a mean plasma concentration of 190 ngml" 1 . There were, however, large variations between individuals.
Oxygen contumption and carbon dioxide production
The cumulative infusion of dobutamine in the present study was associated with an increase in oxygen consumption and carbon dioxide production. The stimulatory effects of ^-agonists on metabolism have long been recognized (Himms Haagen, 1967) and are observed during the administration of isoprenaline i.v. to dogs (Finlay, Wightman and Sykes, 1970) , of dopamine i.v. to dogs (Hall, Young and Scott, 1979) and of salbutamol, a 02-agonist, to asthnlatic patients either orally or i.v. (Neville et al., 1977) . However, in the present study oxygen supply also increased and the oxygen consumption: supply ratio decreased.
Arterial oxygen tension
The significant decrease in arterial oxygen tension observed in this study during the infusion of dobutamine at 15 and 30 /ig kg" 1 min" 1 has also been shown during the infusion of dopamine to patients (Lemaire et al., 1976) and during the infusion of isoprenaline to dogs (Finlay, Wightman and Sykes, 1970) and to patients (Knudson and Constantine, Fordham and Resnekov, 1968; Palmer and Diament, 1968; Palmer et al., 1970) . However, unlike that of dopamine, the action of dobutamine does not appear to depend on the release of endogenous catecholamines (Bodem, Skelton and Sonnenblick, 1974) nor, as in the case of dopamine, is it likely to be further converted to another active form.
The decrease in arterial oxygen tension in this study was accompanied by a decrease in pH, principally caused by an increase in carbon dioxide tension, although at 30ngkg" 1 min' 1 there was also a metabolic component to the acidosis. This may, in part, have been caused by the low pH of the infused dobutamine (pH = 6.1). This decreased pH would cause the oxygen dissociation curve to shift to the right so that, without changing diffusion gradients into the tissue, oxygen supply to the tissue would increase. The decrease in the oxygen consumption: supply ratio would tend to increase Pvo 2 and, in the presence of a constant right to left shunt fraction, would tend to increase Pao 2 -However, changes in Pvo 2 were not significant in this study. 
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Possible causes of the decrease o/Pao 2
The decrease in arterial oxygen tension was caused by a decrease in alveolar Po 2 secondary to the increase in alveolar Pco? and to a small (but nonsignificant) increase in (PAo 2 -fto 2 )-The apparent discrepancy between the significant increase in venous admixture and the non-significant change in (PAQJ -Pao 2 ) may be caused by the increase in mixed venous PO2 resulting from the reduction in oxygen consumption: supply ratio, the hypoxaemia resulting from the increase in venous admixture being offset by the greater PO2 of the blood coming from the areas of lung with a low ventilation: perfusion ratio.
The cause of the increased venous admixture is uncertain although it has been noted previously (Gauthier-Lafaye, 1978) . There were no significant changes in PFA nor in VD/ VT ratios and therefore no major changes in the distribution of blood flow between the upper and lower parts of the lung. PVR decreased, but not significantly, and this effect may have been caused by increase in cardiac output. Two possible causes of the decreased Pao 2 therefore remain: first, that shunt channels may have been opened by the increase in cardiac output, although the changes in cardiac output did not a train significance. Second, the Pvo 2 of the blood from postpulmonary shunt sources may have decreased. Although a decreased PAT3 does not alter anatomical shunt (Aviado et al., 1961) it may decrease bronchial flow, which may reduce bronchial venous PO 2 . Increased oxygen extraction by the myocardium would also result in a decrease in the Po 2 of Thebesian vein blood.
Increased carbon dioxide tensions have been shown to increase venous admixture, but only by a non-significant amount and at carbon dioxide tensions far greater than those achieved in the present study (Finlay, Wightman and Sykes, 1970) . The results of this study do not, therefore, help elucidate the cause of the increased venous admixture observed.
Cardiovascular measurements
The magnitude of the changes in cardiac output observed are comparable to those of Vatner, McRitchie and Braunwald (1974) who showed a 43% increase in cardiac output of conscious dogs with an infusion of 20/igkg" 1 min" 1 of dobutamine and an 80% increase of cardiac output with an infusion rate of 40pgkg~1min" 1 . However, these workers found a minimal increase in arterial pressure, whereas the present study showed a significant decrease of arterial pressure during the infusion of 30ngkg~1min~1 of dobutamine. The present decrease in PAT5 may be a result of either the systemic dilator action of a decreased pH or the f)-agonist effects of dobutamine on the systemic vasculature (Vatner, McRitchie and Braunwald, 1974) . Tinker and others (1976) also found that dobutamine 5ngkg" 1 min" 1 and lOngkg" 1 min" 1 given i.v. to cardiac patients recovering from surgery increased mean arterial pressure by 12%. However, dobutarnine also increased cardiac output significantly.
The inotropic effects of dobutamine have been well documented (Glynne and Lucas, 1978) , as have its peripheral adrenergic agonist effects (Robie, Nutter and McNay, 1973; Robie et al., 1974; Vatner, McRitchie and Braunwald, 1974) . From the present study, it appears that the overall cardiorespiratory effect will be a balance of several different factors and may vary between individuals depending on their initial condition. 
RESUME
Les reponses cardiovasculaires a une perfusion intraveineuse de cMorhydrate de dobutamine ont ete etudiees chez huit chiens anesthesies en ventilation controlee. Lorsqu'on augmente le dibit de perfusion de 2 a 30 ng kg"' min~', ll y a une diminution progressive de la pression arterielle, de la pression capillaire pulmonaire et du pH arteriel. II y a une diminution significative de la pression pamelle arterielle d'oxygene aux nosologies les plus 6levees de dobutamine (15 et 30(igkg~' min ) par rapport aux valeurs initially contrdles. Le debit de dioxyde de car bone, la pression partielle artenelle du dioxyde de carbone, la difference arterio-veineuse et la consommation d'oxygine augmentent pendant la perfusion de dobutamine. (Dependant, la founuture d'oxygene augmente encore plus de telle sorte que le rapport oxygene consomme: oxygene f ourni diminue Nous en concluons que la dobutamine peut diminuer la pression pamelle arterielle en oxygene man qur l'augmentation du debit cardiaque et la diminution du pH arteriel induites par la dobutamine peut augmenter malgre ce fait la quantite d'oxygene delivree aux tissus.
SUMARIO
Se evalu6 las respuestas cardiorespiratorias a una infusi6n i.v. de hipocloruro de dobutamma en ocho perros anestesiados mecanicamente ventilados. A medida que aumentaba el ritmo de infusion de dobutamina de 2 a 30figkg~' min" 1 , tuvo lugar una di3minuci6n progresiva de la presi6n arterial, de la presi6n respiratoria de calce y del pH arterial. Hubo una reducci6n significaava de la tensi6n de oxigeno arterial en las dosis mayores de dobutamina (15 y 30 ng kg" 1 mm" 1 ) en relaci6n con los valores de control iniciales. La producci6n de anhidrido carbonico, la tension arterial de anhidrido carbonico, la mezcla venosa y el consumo de oxigeno aumentaron durante la infusion de dobutamina. Sin embargo, el suministro de oxigeno aumentd aun mas de manera que la relaci6n consumo de oxlgeno/suministro de oxigeno descendi6. Se concluye que la dobutamina puede hacer bajar la tensi6n arterial del oxigeno, pero que el ritmo cardiaco en aumento y el pH arterial en disminud6n producidoi por la dobutamina pueden hacer aumentar el suministro de oxigeno a los tejidos a pesar de ello
